Sands Capital Global Venture Fund Ii, L.p. - Net Worth and Insider Trading
Sands Capital Global Venture Fund Ii, L.p. Net Worth
The estimated net worth of Sands Capital Global Venture Fund Ii, L.p. is at least $9 Million dollars as of 2024-06-08. Sands Capital Global Venture Fund Ii, L.p. is the 10% Owner of Acumen Pharmaceuticals Inc and owns about 3,417,075 shares of Acumen Pharmaceuticals Inc (ABOS) stock worth over $9 Million. Details can be seen in Sands Capital Global Venture Fund Ii, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Sands Capital Global Venture Fund Ii, L.p. has not made any transactions after 2021-07-06 and currently still holds the listed stock(s).
Transaction Summary of Sands Capital Global Venture Fund Ii, L.p.
Sands Capital Global Venture Fund Ii, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sands Capital Global Venture Fund Ii, L.p. owns 1 companies in total, including Acumen Pharmaceuticals Inc (ABOS) .
Insider Ownership Summary of Sands Capital Global Venture Fund Ii, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ABOS | Acumen Pharmaceuticals Inc | 2021-07-06 | 10 percent owner |
Sands Capital Global Venture Fund Ii, L.p. Latest Holdings Summary
Sands Capital Global Venture Fund Ii, L.p. currently owns a total of 1 stock. Sands Capital Global Venture Fund Ii, L.p. owns 3,417,075 shares of Acumen Pharmaceuticals Inc (ABOS) as of July 6, 2021, with a value of $9 Million.
Latest Holdings of Sands Capital Global Venture Fund Ii, L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ABOS | Acumen Pharmaceuticals Inc | 2021-07-06 | 3,417,075 | 2.62 | 8,952,737 |
Holding Weightings of Sands Capital Global Venture Fund Ii, L.p.
Sands Capital Global Venture Fund Ii, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Sands Capital Global Venture Fund Ii, L.p. has made a total of 1 transactions in Acumen Pharmaceuticals Inc (ABOS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Acumen Pharmaceuticals Inc is the acquisition of 450,000 shares on July 6, 2021, which cost Sands Capital Global Venture Fund Ii, L.p. around $7 Million.
Insider Trading History of Sands Capital Global Venture Fund Ii, L.p.
- 1
Sands Capital Global Venture Fund Ii, L.p. Trading Performance
GuruFocus tracks the stock performance after each of Sands Capital Global Venture Fund Ii, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Sands Capital Global Venture Fund Ii, L.p. is -26.49%. GuruFocus also compares Sands Capital Global Venture Fund Ii, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Sands Capital Global Venture Fund Ii, L.p. within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Sands Capital Global Venture Fund Ii, L.p.'s insider trading performs compared to the benchmark.
Performance of Sands Capital Global Venture Fund Ii, L.p.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -25.69 | | | | | |
| Relative Return to S&P 500(%) | -27.83 | | | | | |
Sands Capital Global Venture Fund Ii, L.p. Ownership Network
Sands Capital Global Venture Fund Ii, L.p. Owned Company Details
What does Acumen Pharmaceuticals Inc do?
Who are the key executives at Acumen Pharmaceuticals Inc?
Sands Capital Global Venture Fund Ii, L.p. is the 10 percent owner of Acumen Pharmaceuticals Inc. Other key executives at Acumen Pharmaceuticals Inc include Chief Legal Office & Corp Sec Derek M Meisner , director & President and CEO Daniel Joseph Oconnell , and Chief Financial Officer Matt Zuga .
Acumen Pharmaceuticals Inc (ABOS) Insider Trades Summary
Over the past 18 months, Sands Capital Global Venture Fund Ii, L.p. made no insider transaction in Acumen Pharmaceuticals Inc (ABOS). Other recent insider transactions involving Acumen Pharmaceuticals Inc (ABOS) include a net purchase of 5,161,290 shares made by Ra Capital Healthcare Fund Lp , a net sale of 41,949 shares made by Jeffrey L. Ives , and a net sale of 15,200 shares made by Daniel Joseph Oconnell .
In summary, during the past 3 months, insiders sold 0 shares of Acumen Pharmaceuticals Inc (ABOS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 76,281 shares of Acumen Pharmaceuticals Inc (ABOS) were sold and 5,161,290 shares were bought by its insiders, resulting in a net purchase of 5,085,009 shares.
Acumen Pharmaceuticals Inc (ABOS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Acumen Pharmaceuticals Inc Insider Transactions
Sands Capital Global Venture Fund Ii, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Sands Capital Global Venture Fund Ii, L.p.. You might contact Sands Capital Global Venture Fund Ii, L.p. via mailing address: C/o Sands Capital Ventures, Llc, 1000 Wilson Boulevard, Suite 3000, Arlington Va 22209.
Discussions on Sands Capital Global Venture Fund Ii, L.p.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
